A New Look For Summary Statements

Back To:Science Community Gives Mixed Review To 'Triage' Summary statements for National Institutes of Health grant applications (often referred to as "pink sheets," although they have not been printed on pink paper since 1991) will be formatted differently from now on: Summary statements will consist primarily of the individual reviewers' critiques. Scientific review administrators (SRAs) will write summaries of the s

Written byLiane Reif-lehrer
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Back To:Science Community Gives Mixed Review To 'Triage'


Summary statements for National Institutes of Health grant applications (often referred to as "pink sheets," although they have not been printed on pink paper since 1991) will be formatted differently from now on:

Summary statements will consist primarily of the individual reviewers' critiques. Scientific review administrators (SRAs) will write summaries of the study-section discussion (including budget recommendations, if appropriate) only for applications that undergo full review by the study section. Because "noncompetitive" (NC) applications are not discussed at the study-section meetings, their summary statements will not contain a paragraph summarizing the discussion by the study-section members about the application. Summary statements for scored applications will continue to have a "Description of Project," but NC applications will no longer contain this paragraph. Summary statements for NC applications will contain an explanation of this designation. Summary statements will no longer contain a separate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies